Dexcom, Inc. · NASDAQ:DXCM

Dexcom — Q2 2022 Earnings Presentation

12 slides from Dexcom's earnings presentation, Jul 28, 2022

  1. Slide 1: Dexcom earnings Q2 2022

    bexcom Dexcom earnings Q2 2022

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement This presentation contains “forward” looking statements that are based on our management's beliefs and assumptions and on information currently available to management. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward-looking

  3. Slide 3: Second quarter 2022

    Second quarter 2022 idl © Strong growth with Key Financial Strategic $696 million in revenue Highlights Highlights 17% revenue growth! Achieved record quarterly new Significantly advanced OUS (11% US; 39% OUS?) customer additions reimbursement in several countries Drove over 300 bps Showcased CGM po

  4. Slide 4: Second quarter performance

    Second quarter performance Total Revenue & Organic Growth Rate! Gross Profit and % Margin* ($m™) ($MM) $700 | $595 $650 Soo8 $629 $696 ss, $47 $447 $473 $398 $450 $560 $380 $420 $285 $280 $190 EAC = 30% +27% +20% +23% +16% Eom 70.1% 68.7% 67.7% 63.3% 64.6% $0 $0 Q2'21 Q321 Q4'21 Q122 Q2'22 Q2'21 Q32

  5. Slide 5: 2022 Guidance as of July 28, 2022

    2022 Guidance as of July 28, 2022 2022 Annual Revenue and Profitability Guidance Non-GAAP. Non-GAAP Adjusted Revenue Gross Profit Margin* Operating Margin* EBITDA Margin* Key Considerations + CGM access and awareness momentum global USD g y Previous 282-294 ~65% ~16% ~25% + Final year of significant

  6. Slide 6: Appendix: Revenue Data and GAAP Reconciliations

    bexcom Appendix Revenue Data and GAAP Reconciliations

  7. Slide 7: Dexcom, Inc. GAAP to non-GAAP reconciliation

    Dexcom, Inc. pexcom ‘Three Months Ended June 30, (in miltions) 2022 2021 (As Adjusted) GAAP operating income $ 7.0 $8 101.0 Amortization of intangible assets 19 0s Business transition and related costs ‘D 13.8 = Intellectual property litigation costs 9.2 = Non-GAAP operating income 101.9. 8 10) GAAP

  8. Slide 8: Summary of changes to itemized GAAP and non-GAAP reconciliation

    Below is a summary of the changes in our “Itemized Reconciliation Between GAAP and Non-GAAP Financial Measures” we originally reported for the three months ended June 30, 2021 under the ASC 470-20 legacy guidance compared to the new simplified convertible instruments accounting guidance (ASU 2020-06

  9. Slide 9: Revenue Metrics By Component

    Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 YTD'20 YTD'21 YTD'22 Revenue Metrics By Component Sensor & Other Revenue (millions) (1) (2) $ 325.0 $ 364.5 $ 406.3 $ 465.6 $ 424.3 $ 494.5 $ 547.9 $ 598.6 $ 543.2 $ 597.7 $ 689.5 $ 918.8 $ 1,140.9 Year over year growth 53% 40% 28% 30% 31%

  10. Slide 10: Revenue Metrics By Geography

    Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 YTD'20 YTD'21 YTD'22 Revenue Metrics By Geography US Revenue (millions) $ 292.3 $ 367.1 $ 398.6 $ 451.5 $ 381.2 $ 461.5 $ 489.6 $ 517.1 $ 451.2 $ 511.0 $ 659.4 $ 842.7 $ 962.2 Year over year growth 39% 38% 29% 20% 30% 26% 23% 15% 18% 11% 38

  11. Slide 11: Organic Revenue

    Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 YTD'20 YTD'21 YTD'22 (1) Organic Revenue OUS Revenue - Reported $ 112.8 $ 84.7 $ 102.3 $ 117.4 $ 123.8 $ 133.6 $ 160.6 $ 181.1 $ 177.6 $ 185.2 $ 197.5 $ 257.4 $ 362.8 Impact of Acquired Revenue and Foreign Exchange 1.1 1.1 (2.4) (3.3) (5.4)

  12. Slide 12: Definitions

    Definitions: Amortization of intangible assets – We are required by GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful lives. We exclude these non-cash amortization charges from our non-GAAP financial measures. Business tran

Dexcom — Q2 2022 Earnings Presentation on 6ix